Accessibility Menu
National Research logo

National Research(NASDAQ) NRC

Market Cap$439.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)+27%
5 Year-58%
1 Year+62%
1 Month-13%
$19.49
+3.07%
+0.58Today
After hours$19.54+$0.05 (+0.26%)
National Research last closing stock price
MetricPriceDate
Last closeUSD 19.512026-07-31
National Research stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.27%USD 21.042026-07-24
1 month-12.67%USD 22.342026-07-01
3 month+12.94%USD 17.272026-05-01
Year to date+5.72%USD 18.452025-12-31
1 year+61.52%USD 12.082025-07-31
3 year-49.78%USD 38.852023-08-01
5 year-57.88%USD 46.322021-07-30
Since inception+27.36%USD 15.322013-05-23

National Research Financials at a Glance

Market Cap

$439.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$140.00M

Net Income (TTM)

$5.86M

EPS (TTM)

$0.25

P/E Ratio

78.23

Dividend

$0.60

Beta (Volatility)

0.66 (Low)

Price

$19.49

Volume

167,940.118

Open

$19.08

Previous Close

$19.51

Daily Range

$18.81 - $20.03

52-Week Range

$11.01 - $23.68

Estimated Earnings Date

Oct 26, 2026

NRC News

A couple calculating their finances.

3 High-Yielding Dividend Stocks That Boosted Their Payouts by Over 25% Within the Past Year

David Jagielski, CPASep 3, 2022

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About National Research

National Research Corporation (NRC Health) specializes in understanding and improving the healthcare experience. With over 40 years in the industry, NRC provides solutions that help healthcare providers engage with patients and manage the healthcare journey more effectively. The company’s offerings focus on improving patient insights, loyalty, and organizational performance through comprehensive data analysis and proprietary research methods.

Products and Services

Marketing Solutions: Tracks brand awareness and competitive differentiators using a vast healthcare consumer database.

Experience Solutions: Provides platforms to enhance patient experience, employee engagement, and care transitions.

Reputation Solutions: Offers tools for publishing star ratings and managing online reviews to build reputation.

The Governance Institute: Provides resources for improving healthcare governance and strategic planning.

What Makes National Research Corporation Special

NRC Health stands out for its exclusive focus on the healthcare industry, delivering insights that enhance patient-centered care. The company's comprehensive data collection and analysis capabilities provide healthcare organizations with critical information to improve care delivery and patient satisfaction. NRC's long-standing relationships with leading healthcare systems allow them to leverage a broad network and continuously evolve their offerings.

Five Things You Need to Know

NRC primarily serves the healthcare industry with solutions focused on patient experience and engagement.

The company uses a subscription-based revenue model, ensuring ongoing relationships with clients.

NRC's clients include a majority of the top healthcare systems in the U.S.

Its diversified product offerings cater to various aspects of healthcare operations, from marketing to patient experience.

High customer concentration poses a business risk, with significant revenue coming from a small number of clients.

AI Generated • Apr 16, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

357

CEO

Trent Green, MBA

Website

www.nrchealth.com

Headquarters

Lincoln, NE 68508, US

NRC Financials

Key Financial Metrics (TTM)

Gross Margin

66.79%

Operating Margin

10.53%

Net Income Margin

4.18%

Return on Equity

48.46%

Return on Capital

24.28%

Return on Assets

4.30%

Earnings Yield

1.28%

Dividend Yield

3.08%

Payout Ratio

2.17%

Stock Overview

Market Cap

$439.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

22.54M

Volume

167.94K

Avg. Volume

125.98K

Financials (TTM)

Gross Profit

$93.50M

Operating Income

$14.74M

EBITDA

$23.40M

Operating Cash Flow

$29.51M

Capital Expenditure

-$7.87M

Free Cash Flow

$21.64M

Cash & ST Invst.

$3.33M

Total Debt

$90.03M

National Research Performance Analysis

National Research annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 151,568,0002.4%
20232023-12-31USD 148,580,000-2.0%
20242024-12-31USD 143,060,000-3.7%
20252025-12-31USD 137,390,000-4.0%
National Research sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.7%
Q42025-12-311.7%
Q12026-03-31-1.1%
Q22026-06-301.7%
National Research annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 1.27-13.1%
20232023-12-31USD 1.25-1.1%
20242024-12-31USD 1.04-16.8%
20252025-12-31USD 0.50-51.7%
National Research sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-303929.8%
Q42025-12-31-54.2%
Q12026-03-3169.9%
Q22026-06-30-207.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$35.39M

+4.0%

Gross Profit

$35.39M

+83.2%

Gross Margin

100.00%

N/A

Market Cap

$439.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.23M

N/A

Employees

357

N/A

Net Income

-$3.28M

-2997.2%

EBITDA

-$1.12M

-133.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$3.33M

-36.9%

Total Debt

$90.03M

+11.2%

Accounts Receivable

$9.32M

-27.5%

Inventory

$0.00

N/A

Long Term Debt

$86.01M

+11.7%

Short Term Debt

$4.02M

+2.2%

Return on Assets

4.30%

N/A

Return on Invested Capital

14.57%

N/A

Free Cash Flow

$62.00K

+101.5%

Operating Cash Flow

$1.39M

+221.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VMDViemed Healthcare, Inc.
$11.67-0.77%
PBYIPuma Biotechnology, Inc.
$7.93+0.51%
SOPHSOPHiA GENETICS S.A.
$5.67-1.56%
SPOKSpok Holdings, Inc.
$10.90+1.40%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About NRC

What is the current price of National Research?

National Research is trading at $19.51 per share.

What is the 52-week range for National Research?

Over the past 52 weeks, National Research has traded between $11.01 and $23.68.

How much debt does National Research have?

As of the most recent reporting period, National Research reported total debt of $90.03M.

How much cash does National Research have on hand?

National Research reported $3.33M in cash and cash equivalents in its most recent financial results.

What is National Research’s dividend yield?

National Research currently has a dividend yield of 3.08%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services